It acts as a tumor suppressor in hepatocellular carcinoma (HCC) inducing cell growth arrest, both in vitro and in vivo, by facilitating p53 phosphorylation, at Ser392, via Chk2 (Song et al., 2021; Table 1). Here, CHEK2 is linked to hepatocellular carcinoma.